Page last updated: 2024-11-08

diethylnitrosamine and von Hippel-Lindau Disease

diethylnitrosamine has been researched along with von Hippel-Lindau Disease in 1 studies

Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.

von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shiao, YH1
Ramakrishna, G1
Anderson, LM1
Perantoni, AO1
Rice, JM1
Diwan, BA1

Other Studies

1 other study available for diethylnitrosamine and von Hippel-Lindau Disease

ArticleYear
Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors.
    Cancer letters, 2002, May-08, Volume: 179, Issue:1

    Topics: Adenocarcinoma; Animals; Blotting, Western; Carcinogens; Diethylnitrosamine; DNA Mutational Analysis

2002